Aaron C Tan

34PUBLICATIONS
93CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyOncology and carcinogenesis not elsewhere classifiedCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 11, 2026
Early EGFR inhibition triggers actionable tumour and microenvironmental remodelling in lung cancer.

|Jul 11, 2026
Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?

|May 19, 2026
EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions.

|Jan 10, 2026
Lineage Plasticity and Histologic Transformation in EGFR-TKI Resistant Lung Cancer.

Li Yieng Eunice Lau, Anders Jacobsen Skanderup, Aaron C Tan

|Mar 21, 2025
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC).

Omali Pitiyarachchi, Aaron C Tan

|Mar 14, 2025
The APPLE's core question-upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer.

Joe Q Wei, Alexander Yuile, Aaron C Tan

Pageof 6

Frequent Collaborators

7 joint publications

Mustafa Khasraw

6 joint publications

Daniel S W Tan

5 joint publications

Wan-Teck Lim

4 joint publications

Anders J Skanderup